Have a personal or library account? Click to login
The optimization of needle electrode number and placement for irreversible electroporation of hepatocellular carcinoma Cover

The optimization of needle electrode number and placement for irreversible electroporation of hepatocellular carcinoma

Open Access
|Apr 2012

References

  1. World health organization: Cancer. World Health Organization. 2012. Accessed: March 12, 2012. Available from: http://www.who.int/mediacentre/factsheets/fs297/en/index.html
  2. Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis. World J Gastroenterol 2008; 14: 4300-810.3748/wjg.14.4300
  3. Medicine Net: Liver cancer. Stoppler, M. 2011. Accessed: March 12, 2012. Available from: http://www.medicinenet.com/liver_cancer/article.htm
  4. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012; Epub ahead of print.10.1016/S0140-6736(11)61347-0
  5. Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005; 33: 223-31.10.1007/s10439-005-8981-8
  6. Daniels C, Rubinsky B. Electrical field and temperature model of nonthermal irreversible electroporation in heterogeneous tissues. J Biomech Eng 2009; 131: 071006.10.1115/1.3156808
  7. Rubinsky B. Irreversible electroporation in medicine. Technol Cancer Res Treat 2007; 6: 255-60.10.1177/153303460700600401
  8. Rubinsky B, Onik G, Mikus P. Irreversible electroporation: A new ablation modality-clinical implications. Technol Cancer Res Treat 2007; 6: 37-48.10.1177/153303460700600106
  9. Hofmann GA. Instrumentation and electrodes for in vivo electroporation. In. Jaroszeski MJ, Heller R, Gilbert R, editors. Electrochemotherapy, electrogenetherapy, and transdermal drug delivery. Electrically mediated delivery of molecules to cells. Totowa, New Jersey: Humana Press, 2000. p. 37-61.10.1385/1-59259-080-2:37
  10. Sel D, Mazeres S, Teissie J, Miklavcic D. Finite-element modeling of needle electrodes in tissue from the perspective of frequent model computation. IEEE Trans Biomed Eng 2003; 50: 1221-32.10.1109/TBME.2003.818466
  11. Miklavcic D, Beravs K, Semrov D, Cemazar M, Demsar F, Sersa G. The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J 1998; 74: 2152-8.10.1016/S0006-3495(98)77924-X
  12. Gilbert RA, Jaroszeski MJ, Heller R. Novel electrode designs for electrochemotherapy. Biochim Biophys Acta 1997; 1334: 9-14.10.1016/S0304-4165(96)00119-5
  13. Sersa G, Cemazar M, Semrov D, Miklavcic D. Changing electrode orientation improves the efficacy of electrochemotherapy of solid tumors in mice. Bioelectrochem Bioenerg 1996; 39: 61-6.10.1016/0302-4598(95)01866-2
  14. Corovic S, Pavlin M, Miklavcic D. Analytical and numerical quantification and comparison of the local electric field in the tissue for different electrode configurations. Biomed Eng Online 2007; 6: 37.10.1186/1475-925X-6-37
  15. Cındea NBF, Gournay F, Poignard C. Optimal placement of electrodes in an electroporation process. ESAIM: Proceedings 2010; 30: 34-43.10.1051/proc/2010004
  16. Zupanic A, Corovic S, Miklavcic D. Optimization of electrode position and electric pulse amplitude in electrochemotherapy. Radiol Oncol 2008; 42: 93-101.10.2478/v10019-008-0005-5
  17. Brandisky K, Daskalov I. Electrical field and current distributions in electrochemotherapy. Bioelectrochem Bioenerg 1999; 48: 201-8.10.1016/S0302-4598(98)00232-3
  18. Corovic S, Zupanic A, Miklavcic D. Numerical modeling and optimization of electric field distribution in subcutaneous tumor treated with electrochemotherapy using needle electrodes. IEEE Transactions on Plasma Science 2008; 36: 1665-72.10.1109/TPS.2008.2000996
  19. Miklavcic D, Semrov D, Mekid H, Mir LM. A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim Biophys Acta 2000; 1523: 73-83.10.1016/S0304-4165(00)00101-X
  20. Zupanic A, Corovic S, Miklavcic D, Pavlin M. Numerical optimization of gene electrotransfer into muscle tissue. Biomed Eng Online 2010; 9: 66.10.1186/1475-925X-9-66299075821050435
  21. Kos B, Zupanic A, Kotnik T, Snoj M, Sersa G, Miklavcic D. Robustness of treatment planning for electrochemotherapy of deep-seated tumors. J Membr Biol 2010; 236: 147-53.10.1007/s00232-010-9274-120596859
  22. Miklavcic D, Snoj M, Zupanic A, Kos B, Cemazar M, Kropivnik M, Bracko M, Pecnik T, Gadzijev E, Sersa G. Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy. Biomed Eng Online 2010; 9: 10.10.1186/1475-925X-9-10284368420178589
  23. Sel D, Lebar AM, Miklavcic D. Feasibility of employing model-based optimization of pulse amplitude and electrode distance for effective tumor electropermeabilization. IEEE Trans Biomed Eng 2007; 54: 773-81.10.1109/TBME.2006.88919617518273
  24. Rubinsky B. Irreversible electroporation. Springer. Series in biomedical engineering. 2009. pp 203-21710.1007/978-3-642-05420-4
  25. Zupanic A, Miklavcic D. Method for treatment planning of tissue ablation by irreversible electroporation. In: Dössel O, Schlegel WC, eds. World congress on medical physics and biomedical engineering, september 7 - 12, 2009, Munich, Germany. Springer Berlin Heidelberg; 2009:150-153.10.1007/978-3-642-03895-2_44
  26. Edd JF, Horowitz L, Davalos RV, Mir LM, Rubinsky B. In vivo results of a new focal tissue ablation technique: Irreversible electroporation. IEEE Trans Biomed Eng 2006; 53: 1409-15.10.1109/TBME.2006.87374516830945
  27. Arrive L, Rosmorduc O, Dahan H, Fartoux L, Monnier-Cholley L, Lewin M, et al. Percutaneous acetic acid injection for hepatocellular carcinoma: Using ct fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent. AJR Am J Roentgenol. 2003; 180: 159-62.10.2214/ajr.180.1.180015912490495
  28. Duck FA. Physical properties of tissue. San Diego: Academic Press Inc; 1990. p. 13810.1016/B978-0-12-222800-1.50009-7
  29. Elwassif MM, Kong Q, Vazquez M, Bikson M. Bio-heat transfer model of deep brain stimulation-induced temperature changes. J Neural Eng 2006; 3: 306-15.10.1088/1741-2560/3/4/00817124335
  30. Laufer S, Ivorra A, Reuter VE, Rubinsky B, Solomon SB. Electrical impedance characterization of normal and cancerous human hepatic tissue. Physiol Meas 2010; 31: 995-1009.10.1088/0967-3334/31/7/00920577035
  31. Sel D, Cukjati D, Batiuskaite D, Slivnik T, Mir LM, Miklavcic D. Sequential finite element model of tissue electropermeabilization. IEEE Trans Biomed Eng 2005; 52: 816-27.10.1109/TBME.2005.84521215887531
  32. Ivorra A, Al-Sakere B, Rubinsky B, Mir LM. In vivo electrical conductivity measurements during and after tumor electroporation: Conductivity changes reflect the treatment outcome. Phys Med Biol 2009; 54: 5949-63.10.1088/0031-9155/54/19/01919759406
  33. Haemmerich D, Schutt DJ, Wright AW, Webster JG, Mahvi DM. Electrical conductivity measurement of excised human metastatic liver tumours before and after thermal ablation. Physiol Meas 2009; 30: 459-66.10.1088/0967-3334/30/5/003
  34. Deng ZS, Liu, J. Blood perfusion-based model for characterizing the temperature fluctuation in living tissues. Physica A: Statistical Mechanics and its Applications 2001; 300: 521-30.10.1016/S0378-4371(01)00373-9
  35. Bertacchini C, Margotti PM, Bergamini E, Lodi A, Ronchetti M, Cadossi R. Design of an irreversible electroporation system for clinical use. Technol Cancer Res Treat 2007; 6: 313-20.10.1177/15330346070060040817668939
  36. Edd JF, Davalos RV. Mathematical modeling of irreversible electroporation for treatment planning. Technol Cancer Res Treat 2007; 6: 275-86.10.1177/15330346070060040317668934
  37. Gundersen M, Vernier PT, Marcu L, Li A, Zhu X, Gallam AZ, et al. Ultrashort pulse electroporation: Applications of high pulsed electric fields to induced caspase activation of human lymphocytes. Power Modulator Symposium, 2002 and 2002 High-Voltage Workshop. Conference Record of the Twenty-Fifth International 2002
  38. Cabibbo G, Craxi A. Needle track seeding following percutaneous procedures for hepatocellular carcinoma. World J Hepatol 2009; 1: 62-6.10.4254/wjh.v1.i1.62299925821160966
  39. Tezcan Y, Mehmet, K. Hepatocellular carcinoma with subcutaneous metastasis of the scalp. Radiol Oncol 2011; 45: 292-5.10.2478/v10019-011-0022-7342375322933968
  40. Narayanan G. Irreversible electroporation for treatment of liver cancer. Gastroenterol Hepatol (N Y) 2011; 7: 313-6.
  41. Granot Y, Ivorra A, Maor E, Rubinsky B. In vivo imaging of irreversible electroporation by means of electrical impedance tomography. Phys Med Biol 2009; 54: 4927-43.10.1088/0031-9155/54/16/00619641242
  42. Zhang Y, Guo Y, Ragin AB, Lewandowski RJ, Yang GY, Nijm GM, et al. Mr imaging to assess immediate response to irreversible electroporation for targeted ablation of liver tissues: Preclinical feasibility studies in a rodent model. Radiology 2010; 256: 424-32.10.1148/radiol.10091955290943620656834
  43. Kranjc M, Bajd F, Sersa I, Miklavcic D. Magnetic resonance electrical impedance tomography for monitoring electric field distribution during tissue electroporation. IEEE Trans Med Imaging 2011; 30: 1771-8.10.1109/TMI.2011.214732821521664
  44. Hjouj M, Rubinsky B. Magnetic resonance imaging characteristics of nonthermal irreversible electroporation in vegetable tissue. J Membr Biol 2010; 236: 137-46.10.1007/s00232-010-9281-220631997
  45. Miklavcic D, Towhidi, L. Numerical study of the electroporation pulse shape effect on molecular uptake of biological cells. Radiol Oncol 2010; 44: 34-41.10.2478/v10019-010-0002-3342367222933889
  46. Sahakian AV, Al-Angari HM, Adeyanju OO. Electrode activation sequencing employing conductivity changes in irreversible electroporation tissue ablation. IEEE Trans Biomed Eng 2012; 59: 604-7.10.1109/TBME.2011.218072222194234
  47. Zupanic A, Miklavcic, D. Tissue heating during tumor ablation with irreversible electroporation. Elektrotehniski Vestnik 2011; 78: 42-7.
DOI: https://doi.org/10.2478/v10019-012-0026-y | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 126 - 135
Published on: Apr 19, 2012
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2012 Oyinlolu Adeyanju, Haitham Al-Angari, Alan Sahakian, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 46 (2012): Issue 2 (June 2012)